Malaria Vaccines Market Size, Share And Growth Analysis For 2024-2033

The Business Research Company’s Malaria Vaccines Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033

LONDON, GREATER LONDON, UK, June 20, 2024 /EINPresswire.com/ -- The global malaria vaccines market is experiencing a surge. It is projected to surge from $3.48 billion in 2023 to $4.7 billion in 2024, reflecting a robust compound annual growth rate (CAGR) of 35.2%. This significant growth can be attributed to several factors, including the high global burden of malaria, global health initiatives focused on eradication, funding and grants to support research and development, established malaria control programs, and supportive government regulations.

Rising Mosquito-Borne Disease Incidence Drives Market Growth
The rising incidence of mosquito-borne diseases, including malaria, is a major factor propelling the growth of the malaria vaccines market. The malaria vaccine, particularly the RTS, S/AS01 (RTS,S) vaccine, plays a crucial role in preventing and reducing the impact of these infectious diseases by training the immune system to recognize and attack the malaria parasite. For instance, a November 2023 report by the World Health Organization (WHO) estimated a staggering 249 million cases of malaria globally in 2022, reflecting a concerning rise of 5 million cases compared to 2021. Furthermore, Pakistan reported an alarming increase in cases, with an estimated 2.6 million in 2022 compared to 500,000 cases in 2021. This rise in mosquito-borne diseases is significantly driving the demand for malaria vaccines.

Explore comprehensive insights into the global malaria vaccines market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=13698&type=smp

Major Players and Market Trends
Major players in the malaria vaccines market include Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, and Genvec Inc.

These companies are actively developing innovative products to expand their customer bases and increase revenue. For instance, in November 2022, Malawi became the first country in Africa to launch a pilot program for a new children's malaria vaccine, a significant milestone in collaboration with the World Health Organization. This specific vaccine, known as RTS,S, targets the deadliest malaria parasite, Plasmodium falciparum, and offers promising potential to reduce mortality rates, particularly among young children. Despite a moderate effectiveness rate of 30%, the vaccine has instilled optimism as it has the potential to save many lives among the estimated 400,000 individuals who succumb to malaria each year.

Segments:
• By Agent: Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species
• By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines
• By Route of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes
• By Distribution Channel: Public, Private

Geographical Insights: North America Leads, Asia-Pacific to Witness Fastest Growth
North America was the dominant region in the malaria vaccines market in 2023. However, Asia-Pacific is expected to register the fastest growth rate during the forecast period. The regions covered in the malaria vaccines market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Access the complete report for an in-depth analysis of the global malaria vaccines market: https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Malaria Vaccines Global Market Report 2024 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Malaria Vaccines Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on malaria vaccines market size, malaria vaccines market drivers and trends, malaria vaccines market major players, competitors' revenues, market positioning, and market growth across geographies. The malaria vaccines market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Inactivated Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Swine Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn